연구

연구업적

최근 5년 연구업적 현황
연도 2025년 2024년 2023년 2022년 2021년
SCI 논문
발표편수
책임 196편 179편 173편 163편 184편
공동 132편 147편 120편 115편 136편
합계 328편 326편 293편 278편 320편
3735. Cancer Manipulates Adjacent Adipose Tissue to Exploit Fatty Acids via HIF-1α/CCL2/PPARα Axis: A Metabolic Circuit to Support Tumor Progression
Jeong-Eun Yun, Jieun Seo, Jiwon Koh, Seock-Ah Im, Ki Yong Hong, Yeseon Son, Do-Won Jeong, Junji Fukuda, Jong-Wan Park, Yang-Sook Chun
Adv Sci (Weinh). 2025 Oct 29:e15186 Link
3734. Therapeutic potential of FAPI RLT in oncology: A systematic review
Ruzzeh S, Abdlkadir AS, Paez D, Kang KW, Watabe T, Moghrabi S, Scott AM, Al-Ibraheem A
Theranostics. 2025 Mar 10;15(9):4084-4100 Link
3733. Comparable outcomes for pediatric acute lymphoblastic leukemia patients receiving conditioning with total body irradiation or chemotherapy: A nationwide, Korean registry-based study
Hong KT, Choi JY, Kim H, Im HJ, Hahn SM, Lyu CJ, Ju HY, Yoo KH, Yang EJ, Yoon SS, Park HJ, Choi HS, Chueh HW, Yang DH, Moon JH, Lee JM, Lee JH, Kim JA, Won JH, Kang HJ.
Hemasphere 2025 Jun 17;9(6):e70158 Link
3732. Clinical usefulness of next-generation sequencing-based target gene sequencing in diagnosis of inherited bone marrow failure syndrome
Kwon YD, Hong KT, Lee J, Sunwoo Y, Kim Y, Cho SI, Park HJ, Kim BK, Lee JS, Choi JY, Seong MW, Kang HJ
Ann. Hematol. 2025 May;104(5):2693-2706. Link
3731. Pharmacokinetics of post-transplant cyclophosphamide and its associations with clinical outcomes in pediatric haploidentical hematopoietic stem cell transplantation
Hong KT, Bae S, Sunwoo Y, Lee J, Park HJ, Kim BK, Choi JY, Cho JY, Yu KS, Oh J, Kang HJ.
Biomark Res. 2025 Mar 24;13(1):48. Link
3730. Comparison of oncological outcomes of premenopausal with ovarian function suppression versus postmenopausal women in ER+/HER2- breast cancer
Min Jung Lee a,1 Han-Byoel Lee , Ji-Jung Jung a,c a,1 , Jong-Ho Cheun , Hyeong-Gon Moon a,c b , Eunhye Kang , Wonshik Han
Breast. 2025 Jun:81:104449. Link
3729. Comparison of Long-term Oncological Outcome of Sentinel Lymph Node Mapping Methods (Dye-Only versus Dye and Radioisotope) in Breast Cancer Patients Following Neoadjuvant Chemotherapy
Jinyoung Byeon Wonshik Han 1, Changjin Lim1, Eunhye Kang1, Ji-Jung Jung1, Hong-Kyu Kim1,2,3, Han-Byoel Lee1,2,3, Hyeong-Gon Moon1,2,3,
Cancer Res Treat. 2026;58(1):175-181 Link
3728. Refining Criteria for Axillary Surgery Omission After Neoadjuvant Systemic Therapy in Breast Cancer
Ji-Jung Jung # 1, Hye-Rin Charlotte Kim # 2, Eunhye Kang 1, Hong-Kyu Kim 1 3, Han-Byoel Lee 1 3, Hyeong-Gon Moon 1 3, Wonshik Han
Ann Surg Oncol Ann Surg Oncol. 2025 Aug;32(8):5449-5452 Volume 32, pages 5449–5452, (2025) Link
3727. Impact of PD‑L1 upregulation on immune checkpoint inhibitor efficacy in triple‑negative breast cancer using a 4T1 murine model
A Young Park 1, Ju Hee Kim 1, Sangeun Lee 1, Hoe Suk Kim 1, Hong Kyu Kim 1, Han-Byoel Lee 1, Wonshik Han 1
Int J Oncol. 2025 Jul;67(1):54. Link
3726. Personalized neoadjuvant strategy using 70-gene assay to increase breast-conserving surgery in ER+/HER2- breast cancer
Wonshik Han1,2, Eunhye Kang1, Ji Gwang Jung1, Hong-Kyu Kim1,2, Han-Byoel Lee1,2, Jisun Kim3,Sae Byul Lee3, Hee-Chul Shin4, Chan Sub Park5, Min-Ki Seong5, Hyun-Ah Kim5, Eun-Kyu Kim4 &Byung Ho Son
npj Breast Cancer volume 11, Article number: 57 (2025) Link